Crescent Biopharma, Inc. (CBIO)
11.85
-0.37
(-3.03%)
USD |
NASDAQ |
Dec 19, 16:00
11.88
+0.03
(+0.25%)
After-Hours: 20:00
Crescent Biopharma Total Assets (Quarterly): 138.27M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| XOMA Royalty Corp. | 263.15M |
| Viridian Therapeutics, Inc. | 577.14M |
| DiaMedica Therapeutics, Inc. | 57.05M |
| Denali Therapeutics, Inc. | 1.056B |
| Praxis Precision Medicines, Inc. | 396.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.63M |
| Shareholders Equity (Quarterly) | 116.64M |
| Debt to Equity Ratio | 0.0149 |
| Current Ratio | 6.627 |
| Net Debt Paydown Yield | -0.16% |